お知らせ

論文がアクセプトされました。”折口智樹, 梅田雅孝. シェーグレン病に対するBAFF受容体拮抗薬. リウマチ科.”

論文がアクセプトされました。”Onishi A, Umeda M, et al. Comparison of predictive validity of the Lupus Patient-Reported Outcome and Short-Form-12 for damage accrual in systemic lupus erythematosus. Rheumatology.”

論文がアクセプトされました。”Sumichika Y, Shimizu T, Takatani A, et al. Gender differences in the clinical features and quality of life of Japanese patients with systemic lupus erythematosus: a cross-sectional study based on the LUNA registry. Arthritis Res Ther.”

同門会だより第４３号を発行しました。

論文がアクセプトされました。”Matsuo H, Koga T, Shimizu T, Ide H, Koto S, Kojima K, Fujita Y, Okamoto M, Takatani A, Suzuki T, Matsushita Y, Kawakami A. Pretreatment cytokine signatures as candidate biomarkers for JAK inhibitor response in anti-MDA5 dermatomyositis–related interstitial lung disease: A pilot study. ACR Open Rheumatol. ”

論文がアクセプトされました。”Sumiyoshi R, Koga T, Kamisawa O, Morimoto S, Hosogaya N, Yamamoto H, Hori M, Inaba Y, Hattori Y, Hikake T, Kurokawa T, Hanaoka H, Sato S, Migita K, Ogawa N, Hashimoto M, Kawakami A. A phase II investigator-initiated, continuation trial of 5-aminolevulinic acid hydrochloride/ sodium ferrous citrate (5-ALA-HCl/ SFC) for patients with adult-onset Still’s disease (AOSD) refractory to glucocorticoids. Drug Discov Ther.”

論文がアクセプトされました。”Sako A, Hirokawa M, Matsuse M, Higuchi M, Miyauchi A, Akamizu T, Kawakami A, Mitsutake N. Mutational status of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): molecular analysis should be performed for NIFTPs with nuclear score 3. J Pathol Transl Med.”

論文がアクセプトされました。”Umeda M, Lamiaa M, Umetsu A, Otsuka M, Endo Y, Shimizu T, Fukui S, Sumiyoshi R, Koga T, Kawakami A. Potential Link Between COVID-19 Infection/Vaccination and the Onsets of TAFRO Syndrome and Idiopathic Multicentric Castleman Disease. Immunol Lett.”

論文がアクセプトされました。”Endo Y, Hosogaya N, Fukushige Y, Narita S, Jacobs J, Reiss W, Imai Y, Shimizu T, Koga T, Yamamoto H, Sakai T, Takagi Y, Sumi M, Kawakami A. Efficacy and safety of efgartigimod PH20 SC for Sjögren’s disease-associated dryness: study protocol for an investigator-initiated, multicenter, phase 2, randomized, double-blind, placebo-controlled trial−OASIS study. Front Med.”

論文がアクセプトされました。”Kawakami E, Suzuki T, Tsuji S, Kato T, Abe K, Koga T, Kawakami A. VEXAS syndrome with Vibrio vulnificus sepsis during treatment with Tocilizumab: A case report. Intern Med.”